Amneal to buy Kashiv in $750M deal; raises FY26 EPS outlook (AMRX:NASDAQ)
Summary
Amneal to acquire Kashiv in a $750M deal, raising 2026 revenue and EPS guidance and building a global biosimilars platform.
Description
Amneal to acquire Kashiv in a $750M deal, raising 2026 revenue and EPS guidance and building a global biosimilars platform.
Original reporting
AFBytes is a read-only aggregator. Use the original source for full context and complete reporting.
Open original source